Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNIVERSITY COLLEGE DUBLIN operates in the Biotechnology & Pharmaceuticals technology area. The company currently manages 5 pending office actions, which are distributed among 5 distinct examiners. This distribution ensures that each pending matter is reviewed by a different individual, providing a variety of perspectives across the portfolio's active cases.
Prosecution activity is spread across 3 distinct art units, showing that the company's research interests involve multiple technical examination branches. TRAN, CHRISTINA L is identified as the busiest examiner, though she is only responsible for 1 pending office action. This indicates that the 5 pending actions are split among the distinct examiners involved in the portfolio. Managing 5 pending office actions across 3 distinct art units requires coordination with a diverse group of examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, CHRISTINA L | 1 | 51.6% | +48.2% |
| KANG, TIMOTHY J | 1 | 45.7% | +26.8% |
| MINCHELLA, KAITLYN L | 1 | 26.7% | +21.8% |
| BAKSHI, PANCHAM | 1 | 76.8% | +30.2% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 46.9% | +59.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18687575 | SYSTEM AND METHOD FOR DYNAMICALLY RECOMMENDING FOOTWEAR SIZE, AND FOOTWEAR THEREOF | KANG, TIMOTHY J | — |
| 18564440 | MOLECULAR EVALUATION METHODS | MINCHELLA, KAITLYN L | — |
| 17763441 | NANOPARTICLE COMPOSITIONS FOR GENE THERAPY | LIPPOLIS, ALEXANDRA ROSE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18701230 | NUCLEIC ACID AGENTS FOR TREATMENT OF NON-SMALL-CELL LUNG CANCER | TRAN, CHRISTINA L | — |
| 18687575 | SYSTEM AND METHOD FOR DYNAMICALLY RECOMMENDING FOOTWEAR SIZE, AND FOOTWEAR THEREOF | KANG, TIMOTHY J | — |
| 18564440 | MOLECULAR EVALUATION METHODS | MINCHELLA, KAITLYN L | — |
| 17763509 | HYPERBRANCHED CATIONIC POLYMERS USEFUL AS NUCLEIC ACID DELIVERY VECTORS FOR TRANSFECTING CELLS | BAKSHI, PANCHAM | — |
| 17763441 | NANOPARTICLE COMPOSITIONS FOR GENE THERAPY | LIPPOLIS, ALEXANDRA ROSE | — |
| Art Unit | Apps |
|---|---|
| 3689 | 1 |
| 1623 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18701230 | NUCLEIC ACID AGENTS FOR TREATMENT OF NON-SMALL-CELL LUNG CANCER | TRAN, CHRISTINA L | — | §112 | Non-Final OA | — | Pending | Apr 14, 2024 |
| 18687575 | SYSTEM AND METHOD FOR DYNAMICALLY RECOMMENDING FOOTWEAR SIZE, AND FOOTWEAR THEREOF | KANG, TIMOTHY J | 3689 | §101§102 | Final Rejection | — | Pending | Feb 28, 2024 |
| 18564440 | MOLECULAR EVALUATION METHODS | MINCHELLA, KAITLYN L | — | §101§112 | Non-Final OA | — | Pending | Nov 27, 2023 |
| 17763509 | HYPERBRANCHED CATIONIC POLYMERS USEFUL AS NUCLEIC ACID DELIVERY VECTORS FOR TRANSFECTING CELLS | BAKSHI, PANCHAM | 1623 | §103DP | Non-Final OA | — | Pending | Mar 24, 2022 |
| 17763441 | NANOPARTICLE COMPOSITIONS FOR GENE THERAPY | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§103§112 | Non-Final OA | — | Pending | Mar 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial